Tenofovir Disoproxil Fumarate: Clinical Trials

4 trials for Tenofovir Disoproxil Fumarate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 completed, 1 unknown. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Unknown 1

Follow Tenofovir Disoproxil Fumarate: new trials by email Literature Review of Tenofovir Disoproxil Fumarate trials Research Report on Tenofovir Disoproxil Fumarate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Long-Term Use of Tenofovir (TDF) on Bone Density in Patients With Chronic Hepatitis B
TDF (Tenofovir) - Tenofovir Disoproxil Fumarate, Bone Density
Not yet recruitingAssiut University1722025-05-222025-05-25
Effect of Tenofovir (TDF) on Renal Function in Patients With Chronic Hepatitis B
Tenofovir Disoproxil Fumarate (TDF) - Tenofovir Disoproxil Fumarate, Renal Function Disorder
Not yet recruitingAssiut University1722025-04-102025-04-04
The Effects of Vitamin D and Calcium Supplementation to Parathyroid Hormone in CHB Patients Treated With TDF
Ergocalciferol Capsules, Calcium carbonate - Parathyroid Hormone, Tenofovir Disoproxil Fumarate
Phase 4CompletedMahidol University642022-05-012024-09-05
Switching From Tenofovir Disoproxil Fumarate to Besifovir Dipivoxil Maleate
Besifovir Dipivoxil Maleate, Tenofovir disoproxil fumarate(TDF) - Hepatitis B, Besifovir Dipivoxil Maleate
Phase 4UnknownIlDong Pharmaceutical Co Ltd1522019-05-292019-12-17

Narrower conditions

Hepatitis B (1)  ·  Hepatitis B, Chronic (1)

Broader conditions

Blood-Borne Infections (2)  ·  Communicable Diseases (2)  ·  DNA Virus Infections (2)  ·  Digestive System Diseases (2)  ·  Hepadnaviridae Infections (2)  ·  Hepatitis (2)  ·  Hepatitis, Viral, Human (2)  ·  Infections (2)  ·  Liver Diseases (2)  ·  Virus Diseases (2)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Hepatitis B (1)  ·  Hepatitis, Chronic (1)  ·  Pathologic Processes (1)

Interventions

Tenofovir (3)  ·  Calcium Carbonate (1)  ·  Ergocalciferols (1)

Sponsors

Assiut University (2)  ·  IlDong Pharmaceutical Co Ltd (1)  ·  Mahidol University (1)

Countries

Egypt (2)  ·  South Korea (1)  ·  Thailand (1)

Top investigators

Effat AbdelHady Tony Ahmed, PROFESSOR OF NEPHROLOGY (1)  ·  Mohamed Abdelhakim Omran Mahdy, LECTRURER (1)  ·  Watcharasak Chotiyaputta, Asso Prof (1)

Results publications

PMID 24954675, PMID 11850253, PMID 12472227, PMID 18563054, PMID 19052131, PMID 19274046, PMID 19399802, PMID 19400747, PMID 20171173, PMID 20672993, PMID 21076445, PMID 21639815, PMID 22267714, PMID 24002093, PMID 24119980, PMID 24535626, PMID 26075752, PMID 26563120, PMID 26566064, PMID 26576083, PMID 26732483, PMID 26859637, PMID 27198929, PMID 27915131, PMID 28233741, PMID 28427875, PMID 29020329, PMID 29080644, PMID 29136775, PMID 29359487, PMID 29398866, PMID 29405329, PMID 29628281, PMID 29877316, PMID 30576085, PMID 30687401, PMID 31314188, PMID 32102898, PMID 32185517, PMID 34731856, PMID 35216027, PMID 42025507